[Image source: Gettyimagesbank]Only four startups have received funding to develop novel therapies this year as investment in South Korea' biotech and healthcare sector weakened.Among 15 biotech and healthcare startups that have sought to raise funds this year, only four were successful, The VC, a local market tracker, said Wednesday. This is a significant drop compared with last year when 17 companies received investments for pharmaceutical research and development during the same period.The four startups that received investments for drug development this year are Centenaire Biosciences, Ensol Biosciences, AbTis and AinB.

https://n.news.naver.com/mnews/article/009/0005099032?sid=104

#naver